(Q80800372)

English

Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study

scientific article published on 20 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Akira Togawa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hideyuki Yoshitomi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hiroshi Ito

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Fumio Kimura

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hiroaki Shimizu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Masayuki Ohtsuka

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hiroyuki Yoshidome

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Atsushi Kato

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Shigeaki Sawada

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Masaru Miyazaki

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

20 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

268-273

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

https://scigraph.springernature.com/pub.10.1007/s10147-007-0674-x

0 references

Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of gemcitabine-resistant human pancreatic cancer cells and effect of brefeldin-a on the resistant cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer of the pancreas. 50 years of surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic chemotherapy for pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701005

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-007-0674-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17701005%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80800372&oldid=1967256024"